Quantinuum sets its IPO valuation at $1.68 billion, establishing a new benchmark for the quantum industry.

      The advertised price range was between $53 and $55, while Quantinuum set its price at $60. This difference, reflecting investors' willingness to pay more than the banks' expectations, is the key highlight of the Honeywell-backed company’s initial public offering, which generated $1.68 billion and established a benchmark for the entire quantum computing sector.

      The details are quite simple. Quantinuum offered 28 million shares, an increase from the initially planned 26.5 million, at a price of $60 each, as reported by a source mentioned by Reuters. At this pricing, the company's valuation stands at around $15.6 billion based on the share count in its filings. It is scheduled to begin trading on Nasdaq on Thursday under the ticker QNT, with JPMorgan and Morgan Stanley leading the offering.

      This final amount reflects a progressive rise in ambition. Previous estimates had the offering closer to an increased $1.46 billion, reflecting a valuation of approximately $14.3 billion, which themselves represented an increase from the previously reported $12.7 billion figure after a $20 billion-plus filing circulated. The $1.68 billion priced at $60 surpasses those earlier figures; the perception of the IPO has evolved as the order book stabilized, and the latest figure is the one that matters.

      Investors are purchasing more potential than actual income. Quantinuum disclosed around $31 million in projected revenue for 2025 against a valuation exceeding $15 billion, which indicates that the listing is more about the company's future prospects rather than its current sales.

      Established in 2021 through the merger of Honeywell’s quantum division and Cambridge Quantum, the company focuses on building quantum computers designed to tackle problems that would take classical computers an impractically long time to resolve. It is developing a fault-tolerant machine named Apollo, slated for 2029.

      Honeywell continues to be the main support for the company throughout the offering, expected to retain roughly 49% of the voting rights afterward, while founding shareholders Honeywell and Cambridge Quantum Holdings will keep about 82% of the equity combined.

      The IPO represents, based on these figures, both a partial monetization of an industrial conglomerate’s science investment and the debut of the quantum firm. This arrangement provides Quantinuum with new public capital and allows Honeywell to recognize a market value on an asset it has held since the merger.

      The implications extend beyond Quantinuum’s financials. This represents the largest IPO in the quantum-computing sector to date, making its valuation a reference point for a field that has had numerous scientific achievements but lacked public-market equivalents.

      Competitors already in the market, as well as those considering their own IPOs, now have a valuation benchmark and evidence that public investors are willing to pay above the offered range for quantum investment.

      Whether this enthusiasm endures through future quarterly results remains an open question, and the pricing does not provide an answer. A debut above the expected range signals demand on a single day.

      With Apollo still years away, modest revenue, and the substantial gap between a $15.6 billion valuation and a functioning fault-tolerant computer, this reflects the challenge the sector has faced in closing such distance over the past decade. For now, Quantinuum has set the standard. Trading begins on Thursday.